Skip to main content
Blood Cancer Journal logoLink to Blood Cancer Journal
. 2016 Sep 16;6(9):e471. doi: 10.1038/bcj.2016.85

Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Y Jethava, A Mitchell, M Zangari, S Waheed, C Schinke, S Thanendrarajan, J Sawyer, D Alapat, E Tian, C Stein, R Khan, C J Heuck, N Petty, D Avery, D Steward, R Smith, C Bailey, J Epstein, S Yaccoby, A Hoering, J Crowley, G Morgan, B Barlogie, F van Rhee
PMCID: PMC5056975  PMID: 27635734

Correction to: Blood Cancer Journal (2016) 6, e453; doi:10.1038/bcj.2016.64

The purpose of this corrigendum is to publish grant support omitted in the manuscript 16-BCJ-0175T entitled, ‘Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling defined high-risk multiple myeloma'. Research related to Total Therapy 5 was supported by the P01 Grant awarded to the Myeloma Institute by the National Institutes of Health (P01CA055819).


Articles from Blood Cancer Journal are provided here courtesy of Nature Publishing Group

RESOURCES